BiotechTube
Home/Imvaria/Michael Muelly, MD
MM

Michael Muelly, MD

Co-founder & CTO

Imvaria

Therapeutic Areas

PulmonologyOncology

Imvaria Pipeline

DrugIndicationPhase
FibresolveIdiopathic Pulmonary Fibrosis (IPF) / Interstitial Lung Disease (ILD)Approved
ILD Prognostic BiomarkerInterstitial Lung Disease (ILD) Mortality PredictionDevelopment
Oncology Digital BiomarkersLung CancerDevelopment

Leadership Team at Imvaria

JR
Joshua Reicher, MD
Co-founder & CEO
View full Imvaria profile